SLU-PP-332: A Small Molecule That Changed the Perception of Metabolic Research

In biology, there are processes that have always seemed inextricably linked to movement. Mitochondrial biogenesis. Fatty acid oxidation in skeletal muscle. Aerobic capacity. Traditional science says that these adaptations only arise in response to physical exertion — the body must be provoked to initiate them.

And then came a study that caused both silence and astonishment in the preclinical world. With it, scientists showed that there is a small synthetic molecule that, in mouse models, can induce some of these adaptations without any training.

It is called SLU-PP-332 and has become a phenomenon in laboratories over the past three years.

What is SLU-PP-332?

Unlike classic amino acid chains and larger bioregulatory molecules, SLU-PP-332 is not an amino acid chain. It is a synthetic small lipophilic molecule with a relatively simple chemical structure — formula C₁₈H₂₀N₂O₃, molecular weight approximately 312 g/mol.

It originated in the academic environment of Saint Louis University, hence the prefix "SLU", as a tool for studying a specific group of cellular receptors.

And this is where its story begins.

ERR Receptors – Receptors That Long Lacked a Ligand

In cell biology, there is a family of nuclear receptors called ERR, or estrogen-related receptors. Despite what their name might suggest, they do not bind estrogen and have nothing to do with sex hormones.

These are receptors that control the expression of genes associated with mitochondrial metabolism, oxidative phosphorylation, and fatty acid oxidation in the cell nucleus.

Three Isoforms of ERR Receptors

There are three isoforms:

• ERRα

• ERRβ

• ERRγ

Each controls a slightly different set of genes, but together they form a kind of "metabolic conductor's baton" — managing how the cell handles energy.

Orphan Receptors in Metabolic Regulation

For many years, ERR receptors were referred to in the literature as "orphan receptors". Scientists knew they existed and were important, but they didn't know of any natural or synthetic molecule that could selectively activate them.

It was like having a piano without a pianist — you see the instrument has potential, but you don't know how to play it.

SLU-PP-332 became the first molecule to press these keys simultaneously. It is a pan-agonist of all three ERR receptor isoforms, meaning it binds to the ligand-binding domain of each and stabilizes their active conformation.

What Happens When ERR Receptors Resonate Simultaneously

In 2023, a research team led by Thomas Burris published a study in ACS Chemical Biology that caught the attention of the entire field of metabolic research.

Scientists administered SLU-PP-332 to laboratory mice and observed what happened in their skeletal muscle and liver.

Observed Changes in Preclinical Models

The following changes were observed in preclinical models:

Increased expression of mitochondrial genes
Cells began to produce more proteins needed for energy production.

Increased fatty acid oxidation
Fat became the preferred fuel instead of glucose.

Increased aerobic capacity in mouse models
Laboratory animals under testing conditions exhibited a profile similar to training-adapted models.

Changes in adipocyte dynamics
These changes were observed despite an unchanged diet and unchanged physical activity.

Exercise Mimetic: A Molecule Mimicking the Effects of Training

From these observations, a term quickly established itself in preclinical literature: "exercise mimetic" — a molecule mimicking the effects of training in laboratory models.

SLU-PP-332 induced changes in gene expression in these models that are typically the result of weeks of endurance training in training-adapted animals.

Why It Caused a Stir in Laboratories

The scientific community has long investigated so-called exercise mimetics — molecules that could, in laboratory models, reproduce at least some of the molecular adaptations associated with physical activity.

Until now, candidates for exercise mimetics were either weakly effective in preclinical models or had significant off-target effects.

SLU-PP-332 brought a new perspective to this research. It acts through receptors that are a natural part of metabolic regulation, and its effect in the studied models appears to be tissue-targeted — particularly to skeletal muscle, liver, and brown adipose tissue — not systemically disruptive.

However, it is necessary to be absolutely precise about what we know today — and what we do not.

Limits That Science Has Not Yet Crossed

In any discussion about SLU-PP-332, one fact needs to be clearly stated: all published data come from preclinical models.

Specifically:

In vitro experiments
Data come from experiments on isolated cells, including mouse and human cell lines.

Studies on laboratory rodents
Published results are primarily based on studies in mice.

Transgenic models
Research also includes models where individual ERR receptors are selectively knocked out or overexpressed.

What Has Not Yet Been Proven

Clinical data on humans have not been published. No regulatory authority has evaluated SLU-PP-332 for human use. Pharmacokinetics in humans, long-term safety profile, and potential species differences in metabolism remain open questions.

Scientific conclusions from mouse models cannot be directly extrapolated to human physiology. ERR receptors exist in humans and are conserved, but their tissue-specific regulation, expression profiles, and temporal dynamics of activation may differ from the mouse model.

For this reason, scientists refer to SLU-PP-332 as a research chemical probe — not as a therapeutic candidate. It is a tool that has allowed understanding what ERR receptors do when activated.

Practical Properties for Laboratory Work

For researchers working with SLU-PP-332 in in vitro or animal models, it is important to know its physicochemical properties:

Preparation of Stock Solution

SLU-PP-332 is a hydrophobic small molecule — unlike water-soluble research compounds, it does not dissolve in bacteriostatic water.

For the preparation of stock solutions in preclinical research, dimethyl sulfoxide, or DMSO, is typically used as a solvent.

The final concentration of DMSO in cell cultures should be maintained at a level suitable for the specific experimental model, so that the solvent itself does not affect the measurement results.

Context in Modern Metabolic Science

SLU-PP-332 belongs to a broader group of molecules that, in recent years, have redefined how science perceives metabolic regulation at the cellular level.

Where many hormonal agonists act on hormone receptors in the plasma membrane, SLU-PP-332 goes deeper. It acts directly on nuclear receptors that regulate gene expression within the cell nucleus.

These two pathways do not overlap. They complement each other. And that is why ERR-agonist research maintains a separate trajectory of development.

Conclusion: Why SLU-PP-332 Matters

SLU-PP-332 is not a revolution in the sense of a new drug. It is a revolution in the sense of a scientific tool.

It opened up access for researchers to receptors that had been considered elusive for two decades, and allowed questions to be asked that could not have been asked before.

Questions That SLU-PP-332 Has Opened

What happens to skeletal muscle metabolism in laboratory models when all three ERR isoforms are activated simultaneously?

How do mitochondria respond?

What genes are turned on and off?

The answers to these questions will shape the future of understanding how cells manage their energy. And for science itself, that is already enough for SLU-PP-332 to be one of the most closely watched small molecules of the last three years: the first synthetic molecule that resonates in unison on the piano of ERR receptors in laboratories.

For Researchers

SLU-PP-332 is available in laboratory quality in the Cerebrotech catalog under code CTX-SLU in 10 mg packaging.

Each batch is independently tested for purity by HPLC ≥ 98 % and identity by mass spectrometry.

Certificates of analysis, i.e., COA, are available in the COA Vault section and are specifically linked to the batch codes listed on the product card.

Store at -20 °C. For preparing stock solutions, use DMSO.

References

Billon C, Sitaula S, Banerjee S, et al. Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity. ACS Chemical Biology. 2023;18(4):756–771.

Huss JM, Garbacz WG, Xie W. Constitutive activities of estrogen-related receptors: Transcriptional regulation of metabolism by the ERR pathways in health and disease. Biochimica et Biophysica Acta. 2015;1852(9):1912–1927.

Burris TP, Solt LA, Wang Y, et al. Nuclear receptors and their selective pharmacologic modulators. Pharmacological Reviews. 2013;65(2):710–778.

⚠️ Important Legal Notice

For Research Use Only

This article is for informational and educational purposes only. It summarizes publicly available results of preclinical and in vitro studies published in peer-reviewed journals.

Products offered in the Cerebrotech catalog are intended exclusively for scientific research and laboratory use.

These substances are not registered medicines, nutritional supplements, or medical devices and are not intended for direct human consumption or for the diagnosis, prevention, or treatment of any diseases.